StonvexLoading…
StonvexStonvexStonvexCore line items from HNOI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-10-31 | Annual 2024 2024-10-31 | Annual 2023 2023-10-31 | Annual 2022 2022-10-31 |
|---|---|---|---|---|
Revenue | $65.56K | $4.24K | $13.00K | $34.45K |
Operating Income | $-6.62M | $-3.34M | $-1.93M | $-1.07M |
Net Income | $-6.62M | $-3.34M | $-1.93M | $-1.07M |
EPS (Diluted) | $-0.04 | $-0.01 | $-0.01 | $-0.01 |
Total Assets | $1.73M | $1.25M | $1.26M | $114.30K |
Total Liabilities | $3.36M | $2.65M | $1.46M | $1.22M |
Cash & Equivalents | $9.53K | $20.25K | $235.16K | $51.11K |
Free Cash Flow OCF − CapEx | $-1.19M | $-2.18M | $-2.14M | $-1.12M |
Shares Outstanding | 100.80M | 419.44M | 419.34M | 105.27M |